Acer Therapeutics Receives Complete Response Letter from U.S. FDA for use of EDSIVO™ (celiprolol) in vEDS Patients

June 25, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search